Free Trial
NASDAQ:KRRO

Korro Bio (KRRO) Stock Price, News & Analysis

Korro Bio logo
$42.15 -6.45 (-13.27%)
Closing price 10/17/2025 04:00 PM Eastern
Extended Trading
$42.06 -0.09 (-0.23%)
As of 10/17/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Korro Bio Stock (NASDAQ:KRRO)

Advanced

Key Stats

Today's Range
$41.11
$50.45
50-Day Range
$15.05
$51.36
52-Week Range
$10.29
$85.00
Volume
337,615 shs
Average Volume
287,631 shs
Market Capitalization
$395.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$86.83
Consensus Rating
Buy

Company Overview

Korro Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
45th Percentile Overall Score

KRRO MarketRank™: 

Korro Bio scored higher than 45% of companies evaluated by MarketBeat, and ranked 629th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Korro Bio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    Korro Bio has a consensus price target of $86.83, representing about 106.0% upside from its current price of $42.15.

  • Amount of Analyst Coverage

    Korro Bio has only been the subject of 4 research reports in the past 90 days.

  • Read more about Korro Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Korro Bio are expected to decrease in the coming year, from ($9.52) to ($10.22) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Korro Bio is -4.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Korro Bio is -4.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Korro Bio has a P/B Ratio of 2.46. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Korro Bio's valuation and earnings.
  • Percentage of Shares Shorted

    26.00% of the float of Korro Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Korro Bio has a short interest ratio ("days to cover") of 6.8.
  • Change versus previous month

    Short interest in Korro Bio has recently decreased by 7.43%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Korro Bio does not currently pay a dividend.

  • Dividend Growth

    Korro Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    26.00% of the float of Korro Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Korro Bio has a short interest ratio ("days to cover") of 6.8.
  • Change versus previous month

    Short interest in Korro Bio has recently decreased by 7.43%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Korro Bio has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Korro Bio this week, compared to 3 articles on an average week.
  • Search Interest

    Only 4 people have searched for KRRO on MarketBeat in the last 30 days. This is a decrease of -43% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Korro Bio to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Korro Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.60% of the stock of Korro Bio is held by insiders.

  • Percentage Held by Institutions

    Only 13.18% of the stock of Korro Bio is held by institutions.

  • Read more about Korro Bio's insider trading history.
Receive KRRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Korro Bio and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KRRO Stock News Headlines

Korro Bio management to meet with Piper Sandler
Forget AI, This Will Be the Next Big Tech Breakthrough
After picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be the biggest paradigm shift ever. Yes, even bigger than AI. And he found one Seattle company that's at the center of this new $100 trillion revolution. Click here to get the name of this company, completely free of charge...tc pixel
See More Headlines

KRRO Stock Analysis - Frequently Asked Questions

Korro Bio's stock was trading at $38.07 at the start of the year. Since then, KRRO stock has increased by 10.7% and is now trading at $42.15.

Korro Bio, Inc. (NASDAQ:KRRO) posted its quarterly earnings results on Tuesday, August, 12th. The company reported ($2.74) earnings per share for the quarter, missing the consensus estimate of ($2.54) by $0.20. The business earned $1.46 million during the quarter, compared to the consensus estimate of $0.41 million.

Korro Bio's top institutional investors include CWM LLC (0.03%). Insiders that own company stock include Venture Opportunity Fund Atlas, David L Lucchino and Vineet Agarwal.
View institutional ownership trends
.

Shares of KRRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Korro Bio investors own include Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Home Depot (HD).

Company Calendar

Last Earnings
8/12/2025
Today
10/18/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:KRRO
Previous Symbol
NASDAQ:KRRO
CIK
1703647
Fax
N/A
Employees
70
Year Founded
2018

Price Target and Rating

High Price Target
$147.00
Low Price Target
$25.00
Potential Upside/Downside
+106.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($9.75)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$83.58 million
Net Margins
N/A
Pretax Margin
-1,452.95%
Return on Equity
-61.51%
Return on Assets
-42.87%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.98
Quick Ratio
5.98

Sales & Book Value

Annual Sales
$2.27 million
Price / Sales
174.36
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$17.12 per share
Price / Book
2.46

Miscellaneous

Outstanding Shares
9,390,000
Free Float
8,959,000
Market Cap
$395.79 million
Optionable
No Data
Beta
2.89

Social Links

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:KRRO) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners